| Mrs Ivette Baerga, MSW | |
|
223 Calle Perla, Urbanizacion Estancias, Santa Isabel, PR 00757-2092 | |
| (787) 340-1815 | |
| Not Available |
| Full Name | Mrs Ivette Baerga |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 223 Calle Perla, Santa Isabel, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194037671 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Secondary |
| 1041C0700X | Social Worker - Clinical | 10399 (Puerto Rico) | Primary |
| Entity Name | Inspira Behavioral Care Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063928596 PECOS PAC ID: 5294863262 Enrollment ID: O20141003000758 |
News Archive
Many cancer survivors experience changes in sexual function that leave them feeling guilty and a longing for intimacy, Australian researchers told at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. The researchers say that these sexuality and fertility concerns are often not adequately addressed by doctors.
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene - p53 - is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center.
Insecticide-treated nets may still help prevent malaria despite mosquitoes developing resistance, according to a new study published in Parasites & Vectors.
BioNanomatrix, Inc. and Complete Genomics Inc. (CGI) have announced that they have formed a joint venture that has received an $8.8 million grant award from the U.S. National Institute of Standards and Technology Advanced Technology Program (NIST-ATP) to develop a system capable of sequencing the entire human genome in eight hours at a cost of less than $100
Study findings reveal the significant burden of disease among patients with antineutrophil-cytoplasm antibody associated vasculitis, with many individuals showing irreversible damage shortly after diagnosis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ivette Baerga, MSW 223 Calle Perla, Urbanizacion Estancias, Santa Isabel, PR 00757-2092 Ph: (787) 340-1815 | Mrs Ivette Baerga, MSW 223 Calle Perla, Urbanizacion Estancias, Santa Isabel, PR 00757-2092 Ph: (787) 340-1815 |
News Archive
Many cancer survivors experience changes in sexual function that leave them feeling guilty and a longing for intimacy, Australian researchers told at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. The researchers say that these sexuality and fertility concerns are often not adequately addressed by doctors.
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene - p53 - is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center.
Insecticide-treated nets may still help prevent malaria despite mosquitoes developing resistance, according to a new study published in Parasites & Vectors.
BioNanomatrix, Inc. and Complete Genomics Inc. (CGI) have announced that they have formed a joint venture that has received an $8.8 million grant award from the U.S. National Institute of Standards and Technology Advanced Technology Program (NIST-ATP) to develop a system capable of sequencing the entire human genome in eight hours at a cost of less than $100
Study findings reveal the significant burden of disease among patients with antineutrophil-cytoplasm antibody associated vasculitis, with many individuals showing irreversible damage shortly after diagnosis.
› Verified 9 days ago